Gravar-mail: ATNT-06 EVALUATION OF THE SAFETY OF GSK2256098 AND PHARMACOKINETICS OF (11)C-GSK2256098 IN PATIENTS WITH RECURRENT GLIOBLASTOMA BY POSITRON EMISSION TOMOGRAPHY (PET) IMAGING